ストックスクリーナーアプリを入手
4.45
2.77%
0.12
プレマーケット:
4.56
0.11
+2.47%
前日終値:
$4.33
開ける：
$4.31
24時間の取引高:
4.18M
Relative Volume:
0.97
時価総額：
$1.00B
収益：
-
当期純損益:
$-283.26M
株価収益率:
-3.0272
EPS:
-1.47
ネットキャッシュフロー:
$-273.61M
1週間 パフォーマンス:
+9.61%
1か月 パフォーマンス:
+58.36%
6か月 パフォーマンス:
+40.82%
1年 パフォーマンス:
-30.25%
1日の値動き範囲:
$4.30
$4.59
1週間の範囲:
$3.99
$4.59
52週間の値動き範囲:
$1.26
$7.30
Sana Biotechnology Inc Stock (SANA) Company Profile
名前
Sana Biotechnology Inc
セクター
電話
(206) 701-7914
住所
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
4.45 | 915.75M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-03-18 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 開始されました | Jefferies | Buy |
| 2025-01-08 | アップグレード | TD Cowen | Hold → Buy |
| 2024-11-05 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 開始されました | Rodman & Renshaw | Buy |
| 2024-01-16 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-05 | 開始されました | Citigroup | Buy |
| 2023-08-14 | 開始されました | TD Cowen | Market Perform |
| 2023-05-02 | 開始されました | H.C. Wainwright | Neutral |
| 2021-03-01 | 開始されました | BofA Securities | Buy |
| 2021-03-01 | 開始されました | Goldman | Neutral |
| 2021-03-01 | 開始されました | JP Morgan | Neutral |
| 2021-03-01 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Sana Biotechnology Inc (SANA) 最新ニュース
Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors - GlobeNewswire Inc.
How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes - Benzinga
Sana Biotechnology, Inc. (SANA) Secures an Overweight Rating from Morgan Stanley - MSN
Sana Reports Promising Diabetes Cell Therapy Data at ADA Meeting - MSN
Sana Biotechnology’s SWOT analysis: innovative cell therapy stock faces challenges By Investing.com - Investing.com South Africa
Sana Biotechnology’s SWOT analysis: innovative cell therapy stock faces challenges - Investing.com
Sana Biotechnology's 9% Spike: Technical Signals and Peer Dynamics Drive Unusual Intraday Rally - AInvest
Sana Biotechnology (SANA.O) Surges 9% Amid Technical Bullish Signal: What’s Driving the Move? - AInvest
Sana Biotechnology's 9% Surge: Technical Bullishness or Biotech Momentum? - AInvest
Sana Biotechnology's 9% Surge: Technical Bullish Signal or Sector Shift? - AInvest
Sana Biotechnology’s 9% Surge: Technical Catalysts and Peer Dynamics - AInvest
Sana Biotechnology's 9% Surge: Technicals or a Hidden Catalyst? - AInvest
Sana Biotechnology's 9% Spike: A Technical Catalyst Amid Mixed Biotech Sentiment - AInvest
Sana Biotechnology's 9% Surge: Technical Catalysts and Market Dynamics - AInvest
Sana Biotechnology assumed with an Overweight at Morgan Stanley - TipRanks
Top 10 CRISPR Stocks to Buy Now - Insider Monkey
Sana Biotechnology, Inc.(NasdaqGS: SANA) added to Russell 3000E Value Index - MarketScreener
Sana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment Results - MSN
BofA Remains Bullish on Sana Biotechnology (SANA) - MSN
Sana Biotechnology stock soars after positive diabetes treatment results By Investing.com - Investing.com Canada
SANA Stock on the Rise: A Promising Investment - investchronicle.com
Investigation announced for long-term Investors in shares - openPR.com
Pallas Capital Advisors LLC Makes New $29,000 Investment in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology (NASDAQ:SANA) versus Mosaic ImmunoEngineering (OTCMKTS:CPMV) Critical Analysis - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 25,383 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Lead Plaintiff Appointed in Sana Biotechnology Class Action — Here’s How You Can Recover Your Losses - TradingView
Paysign Leads Our Trio Of Penny Stock Highlights - simplywall.st
Transcript : Sana Biotechnology, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener
Sana Biotechnology to present at 85th annual American Diabetes Association Scientific Sessions - marketscreener.com
Sana Biotechnology to Present First-in-Human Clinical Data on Hypoimmune Islet Cell Therapy for Type 1 Diabetes at ADA Scientific Sessions - Nasdaq
Sana Biotechnology Announces Invited Oral Presentation at - GlobeNewswire
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes ... - Bluefield Daily Telegraph
Sana Bio to Present Novel Immunosuppression-Free Diabetes Cell Therapy Data at ADA | SANA Stock News - Stock Titan
Shareholders Filed a Lawsuit Against $SANA for Misleading Investors About Financial Health - TradingView
Two Sigma Investments LP Grows Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Ameriprise Financial Inc. Invests $29,000 in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Squarepoint Ops LLC Buys 55,625 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology Elects Directors at Annual Meeting - TipRanks
Transcript : Sana Biotechnology, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 02 - MarketScreener
Sana Biotechnology, Inc. (NASDAQ:SANA) Stock Position Raised by Two Sigma Advisers LP - Defense World
Nuveen Asset Management LLC Sells 27,104 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Biggest Stocks in NASDAQ Featuring Sana Biotechnology and Kalkine - Kalkine Media
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by Millennium Management LLC - Defense World
BNP Paribas Financial Markets Makes New Investment in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Bank of America Corp DE Increases Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
ProShare Advisors LLC Grows Stock Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Rosen, Pomerantz To Lead Seattle Biotech Class Action - Law360
Are Investors Declined To Sell Their Sana Biotechnology Inc (NASDAQ: SANA) Holdings? - Stocksregister
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Deutsche Bank AG Sells 72,413 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology to Present at June 2025 Investor Conferences - The Manila Times
Sana Biotechnology Inc (SANA) 財務データ
収益
当期純利益
現金流量
EPS
Sana Biotechnology Inc (SANA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
0.64%
0.37%
大文字化:
|
ボリューム (24 時間):